세계의 심전도(ECG) 모니터링 장비 시장 규모는 2021년에 44억 4,000만 달러, 2030년까지 62억 달러에 달하며, 2024-2030년의 예측 기간에 CAGR로 5.74%의 성장이 전망됩니다. 심전도(ECG) 모니터링 장비의 수요는 주로 심혈관질환의 유병률 상승, 제품 개발에서 기술의 진보, 노년 인구 및 좌식 생활방식의 증가, 심혈관질환에 관한 의식의 향상에 의해 지원되고 있습니다.
심전도(ECG) 모니터링 장비 시장 역학
심전도(ECG) 모니터링 장비는 심박수 인식, 심근 허혈 및 경색 진단, 전도계 결함, 전동기, QT 연장 증후군, 심방 이상, 심낭염, 심실 비대 등의 질병에 가장 중요한 검사로 매우 유익한 것으로 판명되었습니다.
세계보건기구(WHO)(2021)가 발표한 데이터에 따르면 심혈관계 질환(CVD)은 전 세계 주요 사망 원인으로 매년 약 1,790만 명의 목숨을 앗아가는 것으로 추정됩니다.
CVD는 심장과 혈관에 특히 영향을 미치는 질병군으로 분류되며, 관상동맥성 심장질환, 류마티스성 심장질환, 뇌혈관질환 등이 포함됩니다.
또한 WHO(2021)의 동일한 데이터에 따르면 CVD로 인한 사망의 4분의 5 이상이 뇌졸중과 심장마비가 주요 원인이며, 이 중 3분의 1은 70세 미만에서 조기에 발생하며, CVD로 인한 사망의 4분의 3 이상은 중저소득 국가에서 발생한다고 밝혔습니다.
European Society for Cardiology(2017) 자료에 따르면 매년 유럽에서 심혈관질환(CVD)은 390만 명의 사망원인이 되고 있으며, 유럽연합(EU)에서는 180만 명 이상이 사망하고 있습니다. 유럽 전체 사망자의 약 45%, EU에서는 37%를 차지합니다.
또한 ESC가 2019년 발표한 통계에 따르면 ESC 회원국 전체에서 CVD로 인한 사망자 수는 남녀 모두 암으로 인한 사망자 수보다 훨씬 많은 110만 명(남성 110만 명, 여성 88만 7,688명)에 달하지만, 일부 고소득 국가에서는 암으로 인한 사망자 수가 CVD로 인한 사망자 수보다 더 많은 것으로 나타났습니다. 사망자 수를 능가하고 있습니다.
또한 WHO(2017)가 발표한 유럽 데이터에 따르면 CVD로 인한 사망자 수는 유럽에서 약 46배 더 많은 것으로 나타났습니다.
위 사실은 전 세계에서 증가하는 CVD 질병 부담에 대처하기 위한 대책이 절실히 필요하다는 것을 보여줍니다. 죽상동맥경화증, 부정맥과 같은 적응증은 환자의 삶의 질에 영향을 미칩니다. 또한 많은 경우 심장 박동과 활동을 정기적으로 모니터링함으로써 CVD의 심각성을 줄일 수 있습니다. 이는 ECG 모니터링 장비를 배포하여 달성할 수 있습니다. 이러한 기기를 통해 의료진뿐만 아니라 환자도 필요에 따라 전도 시스템의 결함을 진단할 수 있으며, 질병 예후를 개선할 뿐만 아니라 질병을 조기에 진단하는 데 도움이 됩니다. 따라서 세계 심전도 모니터링 기기 시장은 예측 기간 중 주목할 만한 성장을 보일 것으로 예상됩니다.
그러나 개발도상국의 경우, 필요한 의료 인프라가 제대로 갖추어져 있지 않고 제품 승인에 대한 규제 절차가 까다롭다는 점은 ECG 모니터링 기기 시장의 성장을 저해하는 요인으로 작용할 수 있습니다.
심전도 모니터링 기기 시장 부문 분석
ECG 모니터링 기기 시장의 제품 부문에서 홀터 모니터 부문은 예측 기간 중 가장 큰 시장 점유율을 차지할 것으로 예상됩니다. 홀터 모니터는 환자의 비정상적인 심장 기능을 감지하는 데 가장 일반적으로 사용되는 기기입니다. 또한 진단 및 심장의 정상적인 기능을 유지하는 데 도움이 됩니다. 이 기기는 일반적으로 병원에서 사용되며, 환자 심전도 모니터링의 표준으로 가장 선호되는 방식입니다.
또한 심장에 장시간 연결되어 있으므로 기술의 발전으로 심박동 불규칙성을 보다 정확하게 감지할 수 있게 되었으며, 블루투스 센서 기술과 모바일 앱 기술을 탑재한 상업적으로 진보된 홀터 모니터의 개발은 전 세계 ECG 시장의 인기를 촉진할 것으로 예상됩니다. 촉진할 것으로 예측됩니다.
세계의 심전도(ECG) 모니터링 장비 시장에 대해 조사분석했으며, 시장 규모와 예측, 촉진요인과 과제, 기업과 제품 개요 등을 제공하고 있습니다.
Electrocardiogram (ECG) Monitoring Equipment Market By Product (Resting ECG Systems, Stress ECG Systems, Holter Monitors, Cardiopulmonary Stress Testing System), By Type (Single Lead, 3-6 Lead, 12-Lead), By Modality Type (Portable, Stationary, Wearables), by geography is expected to grow at a steady CAGR forecast till 2030 owing to rising technological advancement and increasing prevalence of cardiovascular diseases
Global Electrocardiogram (ECG) Monitoring Equipment Market was valued at USD 4.44 billion in 2021, growing at a CAGR of 5.74% during the forecast period from 2024 to 2030, to reach USD 6.20 billion by 2030. The demand for Electrocardiogram (ECG) Monitoring Equipment is primarily being boosted by the rising prevalence of cardiovascular diseases, technological advancement in product development, increasing geriatric population, sedentary lifestyle, and increasing awareness regarding cardiovascular diseases.
Electrocardiogram (ECG) Monitoring Equipment Market Dynamics:
Electrocardiogram (ECG) Monitoring Equipment was found to be extremely beneficial as it is the most important test for heart rhythm perception, myocardial ischemia, and infarction diagnosis, defects of the conduction system, preexcitation, long QT syndromes, atrial abnormalities, pericarditis, ventricular hypertrophy, and other disorders.
As per the data provided by the World Health Organization 2021, cardiovascular diseases (CVDs) are the leading cause of death across the globe, wherein this group of disease-account for an estimated 17.9 million lives each year.
CVDs are classified as a group of disorders that specifically affect the heart and blood vessels. Some of the CVDs include coronary heart disease, rheumatic heart disease, cerebrovascular disease, and other conditions.
Furthermore, the same data by the WHO 2021 presented that over four out of five CVD deaths list strokes and heart attacks as the main cause, and one-third of these deaths are said to occur prematurely in people below 70 years of age. Over three-quarters of CVD deaths take place in low- and middle-income countries.
According to the data provided by the European Society for Cardiology (ESC) 2017 data, each year cardiovascular disease (CVD) causes 3.9 million deaths in Europe and over 1.8 million deaths in the European Union. They represent about 45% of all deaths in Europe and 37% in the EU.
Additionally, the statistics provided by the ESC for 2019 presented that CVD deaths across ESC member countries far exceeded the cancer deaths for both sexes, affecting 1.1 million males and 887,688 females, although cancer now causes more deaths than CVD in certain high-income countries.
Additionally, as per the data provided by the WHO 2017 data for Europe, deaths, where CVD is listed as a cause, are about 46 times higher in Europe.
The above-mentioned facts state the dire need for measures to address the rising disease burden of CVDs across the globe. Indications such as atherosclerosis, arrhythmias can affect the quality of life of patients. Furthermore, in many cases, the severity of CVDs can be reduced by regular monitoring of cardiac rhythms and activities. This can be achieved by deploying ECG Monitoring Equipment. These devices enable healthcare providers as well as patients to diagnose the defects of the conduction system as per the need, thereby helping in the improvement of disease prognosis as well helping in early disease diagnosis. Therefore, the Global ECG Monitoring Equipment market is expected to witness remarkable growth during the forecast period.
However, non-availability of the required healthcare infrastructure in developing economies, and stringent regulatory process for product approval may prove to be certain restraints to the ECG Monitoring Equipment market growth.
ECG Monitoring Equipment Market Segment Analysis:
ECG Monitoring Equipment by Product (Resting ECG Systems, Stress ECG Systems, Holter Monitors, Cardiopulmonary Stress Testing System), By Type (Single Lead, 3-6 Lead, 12-Lead), By Modality Type (Portable, Stationary, Wearables), By End User (Hospitals, Ambulatory Care, Others), and ECG Monitoring Equipment market by Geography (North America, Europe, Asia-Pacific, and Rest of the World).
ECG Monitoring Equipment market product segment, the Holter monitors segment is expected to amass the largest market share during the forecast period. Holter monitors have been the most commonly used device to detect abnormal heart functioning in patients. They also help in diagnosis and in maintaining the normal functioning of the heart. These devices are generally found in hospitals setups and have been the conventional and most preferred mode of ECG monitoring of patients.
In addition, technological advancements like more accurate detection of any irregularities in the heart's rhythm as it is connected to the heart for a much longer time. The development of commercially advanced Holter monitors, with enabled Bluetooth sensor technology and mobile app technology, is anticipated to drive the popularity of the Global ECG market.
Whereas in the modality type segment, the wearables segment is expected to show faster growth in the forecast period. This can be attributed to the technological advancements, making them accessible to a wider patient population.
Therefore, the constant technological advancements coupled with the extended application of ECG devices present a positive market outlook for the ECG devices among other product types.
North America is expected to dominate the Overall ECG Monitoring Equipment Market:
Among all the regions, North America is expected to account for the largest share in the ECG Monitoring Equipment market. The growing prevalence of cardiovascular diseases, access to better healthcare infrastructure, and growing awareness regarding cardiac diseases coupled with the presence of major ECG Monitoring Equipment market players in the region are predicted to be the major influencing factors in driving the overall growth of the ECG Monitoring Equipment market over the forecast period.
As per the facts provided by the Centers for Disease Prevention and Control (CDC) 2020, heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States where about 655,000 Americans die from heart disease each year.
In addition to the above numbers, the data provided by the American Heart Association mentioned that chronic heart disease remains the leading cause of death in the US, according to 2018 data. The data sheet indicated that in 2018, CHD accounted for approximately 13% of deaths in the US causing 365,744 deaths.
The well-established healthcare infrastructure in the country with supportive reimbursement programs covering the costs for the implantable devices as well as the procedure further encourage people to opt for such devices.
In July 2021, EchoNous, the leader in ultra-portable, AI-guided point-of-care ultrasound (POCUS) tools and software, announced that the company has partnered with Singapore-based Us2.ai, developers of machine learning-driven software that automates the analyses of echocardiographic imagery and measurements.
Considering the presence of a large patient pool in the US coupled with new product launches, the market for ECG Monitoring Equipment looks promising in the United States.
ECG Monitoring Equipment Market Key Players:
Some of the key market players operating in the ECG Monitoring Equipment market include General Electric Company (GE Healthcare), Schiller AG, Koninklijke Philips N.V., Nihon Kohden Corporation, Customed GmbH, CORTEX Biophysik GmbH, Welch Allyn®, Norav Medical, Neurosoft, ACS Diagnostics, Medtronic, Microport Scientific Corporation, LUMED srl Sede legale, iRhythm Technologies, Inc., and others.
Recent Developmental Activities in ECG Monitoring Equipment Market:
In August 2021, Leading smart home medical devices brand Wellue officially announced the launch of its ECG Recorder with AI Analysis.
In July 2021, AliveCor's electrocardiogram (ECG) device, KardiaMobile 6L received the 510(k) clearance from the US Food and Drug Administration (FDA). KardiaMobile 6L is the first-ever handheld ECG device to receive FDA approval for QTc measurement in patients.
In July 2021, Two artificial intelligence (AI) algorithms designed to diagnose people with heart rhythm abnormalities have been approved by the FDA for use with Medtronic's LINQ II cardiac monitor. The AccuRhythm algorithms will be released later this year for use by all implanted LINQ II devices in the US.
Key Takeaways from the ECG Monitoring Equipment Market Report Study
Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the ECG Monitoring Equipment market.
Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
Key companies dominating the Global ECG Monitoring Equipment Market.
Various opportunities are available for the other competitor in the ECG Monitoring Equipment Market space.
What are the top-performing segments in 2023? How these segments will perform in 2030?
Which are the top-performing regions and countries in the current market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for ECG Monitoring Equipment market growth in the coming future?
Target Audience who can be benefited from this ECG Monitoring Equipment Market Ket Report Study
ECG Monitoring Equipment providers
Research organizations and consulting companies
ECG Monitoring Equipment related organization, association, forum, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders in ECG Monitoring Equipment
Various End-users want to know more about the ECG Monitoring Equipment Market and the latest technological developments in the ECG Monitoring Equipment market.
Frequently Asked Questions for ECG Monitoring Equipment Market:
An electrocardiogram (ECG or EKG) records an electrical pulse from the heart. It is the most important test for heart rhythm perception, myocardial ischemia and infarction diagnosis, defects of the conduction system, preexcitation, long QT syndromes, atrial abnormalities, pericarditis, ventricular hypertrophy, and other disorders.
Global Electrocardiogram (ECG) Monitoring Equipment Market was valued at USD 4.44 billion in 2021, growing at a CAGR of 5.74% during the forecast period from 2024 to 2030, to reach USD 6.20 billion by 2030.
The major drivers driving the demand for ECG Monitoring Equipment are the rising prevalence of cardiovascular diseases, technological advancement in product development, increasing geriatric population, sedentary lifestyle, and increasing awareness regarding cardiovascular diseases.
Some of the key market players operating in the ECG Monitoring Equipment market include General Electric Company (GE Healthcare), Schiller AG, Koninklijke Philips N.V., Nihon Kohden Corporation, Customed GmbH, CORTEX Biophysik GmbH, Welch Allyn®, Norav Medical, Neurosoft, ACS Diagnostics, Medtronic, Microport Scientific Corporation, LUMED srl Sede legale, iRhythm Technologies, Inc., and others.
North America is expected to dominate the overall ECG Monitoring Equipment market during the forecast period, 2024 to 2030. This domination is due to the growing prevalence of cardiovascular diseases, access to better healthcare infrastructure, and growing awareness regarding cardiac diseases coupled with the presence of major market players in the region.